Literature DB >> 26828990

Hypo/unmethylated promoter status of Cdk2 gene correlates with its over-expression in ovarian cancer in north Indian population.

A Kanwal1, M Kaur1, A Singh1, S Gupta2, M Sachan3.   

Abstract

Cdk2 has been seen to play crucial roles in cell cycle regulation particularly in G1 to S phase transition and it is known to be involved in cancer progression and cancer cell proliferation. The aim of this study was to evaluate (i) the expression of cdk2 in malignancy of ovarian tumors and (ii) correlation between expression and DNA methylation. Clonal bisulfite sequencing and quantitative PCR analysis was performed for promoter methylation and expression analysis respectively in normal and ovarian tumor tissues. Increased methylation level was observed in normal ovarian tissues than ovarian carcinoma. An inverse relationship was found with expression levels of Cdk2 and DNA methylation.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26828990

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  5 in total

Review 1.  Methylation and ovarian cancer: Can DNA methylation be of diagnostic use?

Authors:  Julie L Hentze; Claus K Høgdall; Estrid V Høgdall
Journal:  Mol Clin Oncol       Date:  2019-01-11

2.  C-Terminal Binding Protein is Involved in Promoting to the Carcinogenesis of Human Glioma.

Authors:  Bo Liu; Gloria Di
Journal:  Mol Neurobiol       Date:  2016-10-03       Impact factor: 5.590

Review 3.  PIM Kinases and Their Relevance to the PI3K/AKT/mTOR Pathway in the Regulation of Ovarian Cancer.

Authors:  Aziz Ur Rehman Aziz; Sumbal Farid; Kairong Qin; Hanqin Wang; Bo Liu
Journal:  Biomolecules       Date:  2018-02-04

4.  Integrative Bioinformatics Approaches to Map Potential Novel Genes and Pathways Involved in Ovarian Cancer.

Authors:  S Udhaya Kumar; D Thirumal Kumar; R Siva; C George Priya Doss; Hatem Zayed
Journal:  Front Bioeng Biotechnol       Date:  2019-12-17

5.  Big data-based identification of methylated genes associated with drug resistance and prognosis in ovarian cancer.

Authors:  Bingbing Yan; Chunqiu Xiong; Feifeng Huang; Mingming Zhang; Yan Mo; Hua Bai
Journal:  Medicine (Baltimore)       Date:  2020-07-02       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.